
|Articles|February 1, 2004
Phakic IOL delivers good results in FDA trial for myopia
Anaheim, CA-An increasing number of IOLs are being developed to achieve improved vision in patients with extreme levels of myopia. One such lens is the Artisan/ Verisyse phakic IOL (Ophtec USA/Advanced Medical Optics), said R. Doyle Stulting, MD, PhD, who reported the results of the FDA clinical study here at the American Academy of Ophthalmology annual meeting.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Study identifies corneal endothelial changes following mRNA COVID-19 vaccination
2
SpyGlass Pharma randomizes first patients in 2 phase 3 clinical trials of the BIM-IOL System
3
STAAR, Broadwood reach cooperation agreement, restructure board after terminated Alcon deal
4
Q&A: Understanding Medicare payment shifts in eye care
5














































